National Institute of Arthritis and Musculoskeletal and Skin Diseases
Overview
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is part of the National Institutes of Health (NIH) and the Department of Health and Human Services (HHS). NIAMS supports research into the causes, treatment, and prevention of arthritis, and musculoskeletal and skin diseases. The institute also trains basic and clinical scientists to conduct this research and disseminates information on research progress.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cytex Therapeutics, Inc. | - | Grant | Co-investor |
| Sharklet Technologies | Jul 2017 | Grant | Co-investor |
| Imbed Biosciences | Sep 2019 | Grant | Lead |
| Rivanna Medical | Nov 2023 | Grant | Lead |
| NovoMedix, LLC | - | Grant | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is National Institute of Arthritis and Musculoskeletal and Skin Diseases based?
National Institute of Arthritis and Musculoskeletal and Skin Diseases is headquartered in Bethesda, Maryland, United States.
When was National Institute of Arthritis and Musculoskeletal and Skin Diseases founded?
National Institute of Arthritis and Musculoskeletal and Skin Diseases was founded in 1986.
How many portfolio companies does National Institute of Arthritis and Musculoskeletal and Skin Diseases have?
National Institute of Arthritis and Musculoskeletal and Skin Diseases has 34 portfolio companies in Caplight's dataset.
What are some companies in National Institute of Arthritis and Musculoskeletal and Skin Diseases's portfolio?
Portfolio companies visible on Caplight include Cytex Therapeutics, Inc., Sharklet Technologies, Imbed Biosciences, Rivanna Medical, NovoMedix, LLC.
What was National Institute of Arthritis and Musculoskeletal and Skin Diseases's most recent investment shown here?
National Institute of Arthritis and Musculoskeletal and Skin Diseases's most recent investment in this portfolio sample was in Rivanna Medical in 2023.
What sectors does National Institute of Arthritis and Musculoskeletal and Skin Diseases focus on?
National Institute of Arthritis and Musculoskeletal and Skin Diseases focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does National Institute of Arthritis and Musculoskeletal and Skin Diseases focus on?
National Institute of Arthritis and Musculoskeletal and Skin Diseases typically invests at the MultiStage stage.
What is National Institute of Arthritis and Musculoskeletal and Skin Diseases's AUM?
National Institute of Arthritis and Musculoskeletal and Skin Diseases's assets under management are estimated between $500.0M and $1.0B.